Reflecting on 25 years with MYC

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature Reviews. Cancer

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc2231PMID 19029958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MYC in mammalian epidermis: how can an oncogene stimulate differentiation?

  2008cited by this paper
• Module map of stem cell genes guides creation of epithelial cancer stem cells.

  2008cited by this paper
• Integration of external signaling pathways with the core transcriptional network in embryonic stem cells.

  2008cited by this paper
• Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas

  2008cited by this paper
• Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras

  2008cited by this paper
• Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis

  2008cited by this paper
• Why myc? An unexpected ingredient in the stem cell cocktail.

  2008cited by this paper
• N-myc coordinates retinal growth with eye size during mouse development.

  2008cited by this paper
• The c-myc promoter: still MysterY and challenge.

  2008cited by this paper
• The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.

  2008cited by this paper
• FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

  2008cited by this paper
• An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

  2008cited by this paper
• Epstein-Barr Virus Nuclear Antigen 3C Interacts with and Enhances the Stability of the c-Myc Oncoprotein

  2008cited by this paper
• A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins

  2008cited by this paper
• Mechanisms of Disease: cancer stem cells—targeting the evil twin

  2008cited by this paper
• How the c-myc promoter works and why it sometimes does not.

  2008cited by this paper
• A Multi-Center Randomised Controlled Trial of Gatifloxacin versus Azithromycin for the Treatment of Uncomplicated Typhoid Fever in Children and Adults in Vietnam

  2008cited by this paper
• The interplay between MYC and HIF in cancer

  2008cited by this paper
• Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

  2008cited by this paper
• Non-transcriptional control of DNA replication by c-Myc

  2007cited by this paper
• c-Myc Blazing a Trail of Death: Coupling of the Mitochondrial and Death Receptor Apoptosis Pathways by c-Myc

  2007cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• The world according to MYC

  2007cited by this paper
• The Myc Transactivation Domain Promotes Global Phosphorylation of the RNA Polymerase II Carboxy-Terminal Domain Independently of Direct DNA Binding

  2007cited by this paper
• In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

  2007cited by this paper
• The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth.

  2007cited by this paper
• Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response

  2007cited by this paper
• CUL7 is a novel antiapoptotic oncogene.

  2007cited by this paper
• Supercoil-driven DNA structures regulate genetic transactions.

  2007cited by this paper
• Identification of Internal Ribosome Entry Segment (IRES)-trans-Acting Factors for the Myc Family of IRESs

  2007cited by this paper
• Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.

  2007cited by this paper
• The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.

  2007cited by this paper
• Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

  2007cited by this paper
• The Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Stabilizes and Activates c-Myc

  2007cited by this paper
• The Ever Expanding Role for c-Myc in Promoting Genomic Instability

  2007cited by this paper
• FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.

  2007cited by this paper
• Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC

  2007cited by this paper
• Mnt takes control as key regulator of the myc/max/mxd network.

  2007cited by this paper
• 25 years of the c-Myc oncogene.

  2006cited by this paper
• The c-Myc target gene network.

  2006cited by this paper
• Oncogenic pathway signatures in human cancers as a guide to targeted therapies

  2006cited by this paper
• The Myc oncoprotein as a therapeutic target for human cancer.

  2006cited by this paper
• Mechanisms of transcriptional repression by Myc.

  2006cited by this paper
• The Ins and Outs of MYC Regulation by Posttranslational Mechanisms*

  2006cited by this paper
• The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.

  2006cited by this paper
• Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.

  2006cited by this paper
• Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2‐dependent pathway

  2006cited by this paper
• Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function.

  2006cited by this paper
• The MAX-interacting transcription factor network.

  2006cited by this paper
• Genetic regulators of large-scale transcriptional signatures in cancer

  2006cited by this paper
• c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.

  2006cited by this paper
• N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.

  2006cited by this paper
• Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.

  2006cited by this paper
• Conditional transgenic models define how MYC initiates and maintains tumorigenesis.

  2006cited by this paper
• Structural aspects of interactions within the Myc/Max/Mad network.

  2006cited by this paper
• Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms.

  2006cited by this paper
• The Mad side of the Max network: antagonizing the function of Myc and more.

  2006cited by this paper
• The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism.

  2006cited by this paper
• Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.

  2006cited by this paper
• Mechanism of transcriptional activation by the Myc oncoproteins.

  2006cited by this paper
• Global mapping of c-Myc binding sites and target gene networks in human B cells

  2006cited by this paper
• Lessons learned from Myc/Max/Mad knockout mice.

  2006cited by this paper
• Myc in model organisms: a view from the flyroom.

  2006cited by this paper
• Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

  2006cited by this paper
• The Oscar-worthy role of Myc in apoptosis.

  2006cited by this paper
• c-Myc, genome instability, and tumorigenesis: the devil is in the details.

  2006cited by this paper
• c-Myc and downstream targets in the pathogenesis and treatment of cancer.

  2006cited by this paper
• Myc influences global chromatin structure

  2006cited by this paper
• Myc-binding-site recognition in the human genome is determined by chromatin context

  2006cited by this paper
• Myc target transcriptomes.

  2006cited by this paper
• Specific Requirement for Bax, Not Bak, in Myc-induced Apoptosis and Tumor Suppression in Vivo*

  2006cited by this paper
• Myc/Max/Mad in invertebrates: the evolution of the Max network.

  2006cited by this paper
• A microRNA polycistron as a potential human oncogene

  2005cited by this paper
• c-Myc-regulated microRNAs modulate E2F1 expression

  2005cited by this paper
• Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

  2005cited by this paper
• Functional and physical communication between oncoproteins and tumor suppressors

  2005cited by this paper
• Transcriptional regulation and transformation by Myc proteins

  2005cited by this paper
• The great MYC escape in tumorigenesis.

  2005cited by this paper
• Polycomb mediates Myc autorepression and its transcriptional control of many loci in Drosophila.

  2005cited by this paper
• LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism

  2005cited by this paper
• Probing tumor phenotypes using stable and regulated synthetic microRNA precursors

  2005cited by this paper
• Cancer therapeutics: targeting the dark side of Myc.

  2005cited by this paper
• Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis

  2005cited by this paper
• The Transcriptional Repressor dMnt Is a Regulator of Growth in Drosophila melanogaster

  2005cited by this paper
• c-Myc Is Required for the Formation of Intestinal Crypts but Dispensable for Homeostasis of the Adult Intestinal Epithelium

  2005cited by this paper
• c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I

  2005cited by this paper
• c-myc expression: keep the noise down!

  2005cited by this paper
• c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus.

  2005cited by this paper
• Myc, cell competition, and compensatory proliferation.

  2005cited by this paper
• Could MYC Induction of Mitochondrial Biogenesis be linked to ROS Production and Genomic Instability?

  2005cited by this paper
• The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation.

  2005cited by this paper
• Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development

  2005cited by this paper
• c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription

  2005cited by this paper
• MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

  2004cited by this paper
• Drosophila myc regulates organ size by inducing cell competition.

  2004cited by this paper
• p19ARF directly and differentially controls the functions of c-Myc independently of p53

  2004cited by this paper
• c-Myc as a therapeutic target in cancer

  2004cited by this paper
• c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation.

  2004cited by this paper
• Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia

  2004cited by this paper
• The Life Cycle of C-Myc: From Synthesis to Degradation

  2004cited by this paper

• Nucleolus as a cornerstone linking proliferation and metabolism to cellular responses to stress: involvement of transcription factors MYC and p53.

  2026cites this paper
• The N-Myc MB0-MBI region interacts specifically and dynamically with the N-lobe of Aurora kinase A

  2026cites this paper
• MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance

  2026cites this paper
• Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.

  2026cites this paper
• Gene Expression and Immunohistochemical Analyses of c-Myc in Canine and Feline Soft Tissue Fibrosarcomas.

  2026cites this paper
• c-Myc: Central Regulator of Autophagy and Senescence in Cancer.

  2026cites this paper
• DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation

  2025cites this paper
• Sulfinyl Aziridines as Stereoselective Covalent Destabilizing Degraders of the Oncogenic Transcription Factor MYC.

  2025cites this paper
• Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation

  2025cites this paper
• PI3K/AKT/mTOR pathway and c-Myc inhibit hepatocyte suspension under simulated microgravity

  2025cites this paper
• Probing the Structural Dynamics of the Unbound MAX Protein: Insights from Well-Tempered Metadynamics

  2025cites this paper
• Serine metabolism reprogramming in cancer: a multi-tiered regulatory framework.

  2025cites this paper
• MYCN as an oncogene in pediatric brain tumors

  2025cites this paper
• Cell-based high-throughput screening using a target–NanoLuc fusion construct to identify molecular glue degraders of c-Myc oncoprotein

  2025cites this paper
• MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma

  2025cites this paper
• Inferring Gene Regulatory Networks From Single‐Cell RNA Sequencing Data by Dual‐Role Graph Contrastive Learning

  2025cites this paper
• Pan-cancer Myc modulator that targets Myc-α-tubulin interaction to drive selective mitotic catastrophe

  2025cites this paper
• Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the 'Undruggable' MYC Oncogene and Potentiate Immune Checkpoint Blockage.

  2025cites this paper
• Racial Differences in the Molecular Genetic Biomarkers of Diffuse Large B-Cell Lymphoma

  2025cites this paper
• Acquisition of discrete immune suppressive barriers contributes to the initiation and progression of preinvasive to invasive human lung cancer

  2025cites this paper
• VEGFA, MYC, and JUN are abnormally elevated in the synovial tissue of patients with advanced osteoarthritis

  2025cites this paper
• Fragile X mental retardation 1 gene FMR1 promotes proliferation, migration, and invasion of gastric cancer cells via c-MYC

  2025cites this paper
• Comprehensive dissection of cis-regulatory elements in a 2.8 Mb topologically associated domain in six human cancers

  2025cites this paper
• Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy

  2025cites this paper
• Investigating the Expression and Role of N-Myc in Spermatogonial Stem Cells and Male Infertility.

  2025cites this paper
• ZCCHC4 regulates esophageal cancer progression and cisplatin resistance through ROS/c-myc axis

  2025cites this paper
• c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a.

  2025cites this paper
• Discovery of Bi-magnolignan as a novel BRD4 inhibitor inducing apoptosis and DNA damage for cancer therapy.

  2025cites this paper
• Bioinformatics study and cytotoxicity of several curcumin analogues in ovarian cancer

  2025cites this paper
• Engineered Peptide Coacervates Enable Efficient Intracellular Delivery of the MYC Inhibitor omoMYC

  2025cites this paper
• Beyond the Limit: MYC Mediates Tumor Immune Escape

  2025cites this paper
• Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer.

  2025cites this paper
• MYC Point Mutations in Cancer: A Reboot and a Sequel

  2025cites this paper
• Molecular Mechanisms of Biochanin A in AML Cells: Apoptosis Induction and Pathway-Specific Regulation in U937 and THP-1

  2025influential citation
• Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements.

  2025cites this paper
• Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration.

  2025cites this paper
• An Integrative Drug‐Induced Transcriptomic Analysis Identifies Novel MYC Antagonists and Potential Synergistic Drug Combinations

  2025cites this paper
• Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathway.

  2025cites this paper
• Highly Specific Inhibition of c-Myc Oncogene Expression through Shifting the G-Quadruplex toward a Triplex Structure.

  2025cites this paper
• MicroRNAs as the critical regulators of ubiquitin-proteasome system through F-box protein targeting during tumor progression

  2025cites this paper
• The crosstalk between glutathione metabolism and non-coding RNAs in cancer progression and treatment resistance

  2025cites this paper
• Transcriptional activation and coactivator binding by yeast Ino2 and human proto-oncoprotein c-Myc

  2025cites this paper
• The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response

  2025cites this paper
• Valerate enhances flesh hardness by inhibiting muscle proliferation and differentiation in Nile tilapia (Oreochromis niloticus): An in vivo and in vitro study

  2025cites this paper
• Regulatory role of transcription factor c-Myc in the pathogenesis of psoriasis

  2025cites this paper
• Heterogeneity of acute myeloid leukemia patients explored through single-cell and single-sample gene regulatory networks.

  2025cites this paper
• Epigenetic Disruption as a Molecular Signature in Idiopathic Nonobstructive Azoospermia

  2025cites this paper
• MYC and AP-1 oncogenes synergistically bind enhancers to rewire transcription

  2025cites this paper
• MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian Cancer

  2025cites this paper
• Attractor Landscape Analysis Reveals a Reversion Switch in the Transition of Colorectal Tumorigenesis

  2025cites this paper
• AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer

  2025cites this paper
• Temporal Myc dynamics permit mitotic bypass, promoting polyploid phenotypes.

  2025cites this paper
• Cryo-EM structures reveal the PP2A–B55α and Eya3 interaction that can be disrupted by a peptide inhibitor

  2025cites this paper
• Genetic-epigenetic interactions (meQTLs) in orofacial clefts etiology

  2025cites this paper
• Salicylate-Elicited Activation of AMP-Activated Protein Kinase Directly Triggers Degradation of C-Myc in Colorectal Cancer Cells

  2025cites this paper
• Investigation of simple BODIPY dyes as G-quadruplex recognizing ligands

  2025cites this paper
• MYC in cancer: from undruggable target to clinical trials

  2025cites this paper
• Sulfinyl Aziridines as Stereoselective Covalent Destabilizing Degraders of the Oncogenic Transcription Factor MYC

  2025cites this paper
• Targeting MYC with protein drugs.

  2025cites this paper
• Targeted degradation of CDK9 potently disrupts the MYC-regulated network.

  2025cites this paper
• MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastoma

  2025cites this paper
• RNF112 Facilitates Ubiquitin‐Mediated Degradation of c‐Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer

  2025cites this paper
• The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia

  2025cites this paper
• Integrative CRISPR Screens and RNA-Omics Discover an Essential Role for PUF60-3’ Splice Site Interactions in Cancer Progression

  2025cites this paper
• Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma

  2025cites this paper
• Differential MYC Phosphorylation Drives the Divergent Cholangiocyte Response to Stress

  2025cites this paper
• A dominant role of TGFβ in regulating T-cell size and physiology

  2025cites this paper
• Design and Synthesis of PARP/CDK6 Dual-Target Inhibitors Modulating of Wnt/β-Catenin Signaling Pathway for the Treatment of BRCA Wild-Type TNBC.

  2025cites this paper
• STK32C promotes colon tumor progression through activating c-MYC signaling

  2025cites this paper
• Pharmacologic inhibition of BMI1 exerts antitumor effects against MYCN-amplified neuroblastoma, with activation of the p53 pathway

  2025cites this paper
• Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics

  2025cites this paper
• Flexible long-chain substituted quinoxalines as G-quadruplex binders exert antitumor effects via cGAS-STING immunomodulatory pathway.

  2025cites this paper
• The complexity of tobacco smoke-induced mutagenesis in head and neck cancer

  2024cites this paper
• MYCN drives oncogenesis by cooperating with the histone methyltransferase G9a and the WDR5 adaptor to orchestrate global gene transcription

  2024cites this paper
• Cinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells in vitro and in vivo

  2024cites this paper
• Aging-related defects in macrophage function are driven by MYC and USF1 transcriptional programs.

  2024cites this paper
• CD4 T Cell-Derived IL-21 Is Critical for Sustaining Plasmodium Infection-Induced Germinal Center Responses and Promoting the Selection of Memory B Cells with Recall Potential.

  2024cites this paper
• Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC

  2024cites this paper
• MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications

  2024cites this paper
• C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer

  2024cites this paper
• G-quadruplex-mediated genomic instability drives SNVs in cancer

  2024cites this paper
• Therapeutic approaches targeting oncogenic proteins in myeloid leukemia: challenges and perspectives

  2024cites this paper
• ALKBH5 promotes malignant proliferation of renal clear cell carcinoma by activating the MAPK pathway through binding to HNRNPDL.

  2024cites this paper
• The mechanism of action and experimental verification of Gan-song Yin on renal clear cell carcinoma based on network pharmacology and bioinformatics

  2024cites this paper
• Regulation of chromatin architecture by transcription factor binding

  2024cites this paper
• Navigating the Challenges of Primary Angiosarcoma of the Breast: Comprehensive Review and A Case Report

  2024cites this paper
• DiQuinoline-MonoQuinazoline: A Flat Proton Binder and Its Application as a Polyaromatic Hydrocarbon Scavenger and G4 Ligand.

  2024cites this paper
• Exploring tumor microenvironment interactions and apoptosis pathways in NSCLC through spatial transcriptomics and machine learning

  2024cites this paper
• Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC

  2024cites this paper
• Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor

  2024cites this paper
• ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signaling.

  2024cites this paper
• FABP6 serves as a new therapeutic target in esophageal tumor

  2024cites this paper
• PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells

  2024cites this paper
• MYC the oncogene from hell: Novel opportunities for cancer therapy.

  2024cites this paper
• Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase

  2024cites this paper
• Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor DLBCL

  2024cites this paper
• Regulation of lipid and serine metabolism by the oncogene c-Myc.

  2024cites this paper
• Enhancement of gold-curcumin nanoparticle mediated radiation response for improved therapy in cervical cancer: a computational approach and predictive pathway analysis

  2024cites this paper
• Angiosarcoma of the breast gland: molecular genetic profile, diagnosis and treatment

  2024cites this paper
• Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology

  2024cites this paper